{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:03:56Z","timestamp":1783613036438,"version":"3.55.0"},"reference-count":125,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"by GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/14760584.2025.2502030","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T05:18:52Z","timestamp":1747113532000},"page":"373-383","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Toward elimination of hepatitis A and B in Europe: vaccination successes, challenges, and opportunities"],"prefix":"10.1080","volume":"24","author":[{"given":"Maria","family":"Buti","sequence":"first","affiliation":[{"name":"CIBER del Instituto Carlos III","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bonanni","sequence":"additional","affiliation":[{"name":"University of Florence","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimzing","family":"Ladep","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital","place":["Norwich, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Papatheodoridis","sequence":"additional","affiliation":[{"name":"Medical School of National and Kapodistrian University of Athens School of Health Sciences","place":["Athens, Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Fr\u00fchwein","sequence":"additional","affiliation":[{"name":"Dr. Fr\u00fchwein & Partner - Praxis f\u00fcr Allgemein-, Tropen- und Reisemedizin","place":["M\u00fcnchen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"James","sequence":"additional","affiliation":[{"name":"World Hepatitis Alliance","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Ward","sequence":"additional","affiliation":[{"name":"Coalition for Global Hepatitis Elimination, Task Force for Global Health","place":["Decaturx, USA"]},{"name":"Emory University","place":["Atlanta, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Vetter","sequence":"additional","affiliation":[{"name":"Data and Predictive Sciences","place":["M\u00fcnchen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Cacciatore","sequence":"additional","affiliation":[{"name":"Global Medical Affairs","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Kesters","sequence":"additional","affiliation":[{"name":"BeLux Medical Affairs Vaccines","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavitra","family":"Dewda","sequence":"additional","affiliation":[{"name":"Global Medical Affairs","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[{"name":"University of Antwerp","place":["Antwerp, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"e_1_3_6_3_1","unstructured":"World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries 2024. [cited 2024 Sep 24]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240091672"},{"key":"e_1_3_6_4_1","unstructured":"World Health Organization. Hepatitis B. 2024 [cited 2024 Jun 5]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"key":"e_1_3_6_5_1","first-page":"493","article-title":"WHO position paper on hepatitis a vaccines \u2013 October 2022","volume":"40","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. WHO position paper on hepatitis a vaccines \u2013 October 2022. Wkly Epidemiological Rec. 2022;40:493\u2013512.","journal-title":"Wkly Epidemiological Rec"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13101900"},{"key":"e_1_3_6_7_1","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021: towards ending viral hepatitis 2016. [cited 2024 Jun 27]. Available from https:\/\/iris.who.int\/bitstream\/handle\/10665\/246177\/WHO-HIV-2016.06-eng.pdf?sequence=1"},{"key":"e_1_3_6_8_1","unstructured":"European Center for Disease Prevention and Control. Hepatitis B. Annual Epidemiological Report for 2022 2024. [updated April 2024; Accessed on 2024]. Available from May 30. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/AER%20HEPB%202022_0.pdf."},{"key":"e_1_3_6_9_1","unstructured":"World Health Organization. Hepatitis B in the WHO European region. Fact sheet. 2022 [cited 2024 Dec 13]. Available from https:\/\/www.who.int\/europe\/publications\/hepatitis-b-in-the-who-european-region-factsheet-july-2022"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-2667(23)00149-4"},{"key":"e_1_3_6_11_1","unstructured":"European Center for Disease Prevention and Control. Prevention of hepatitis B and C in the EU\/EEA April 2024. [cited 2024 May 28]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Evidence-brief-hepatitis-B-C-prevention-EU-EEA-2024_0.pdf"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.30.2200738"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08433-3"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13821"},{"key":"e_1_3_6_15_1","unstructured":"European Center for Disease Prevention and Control. Hepatitis A: annual epidemiological report for 2022. [cited 2024 Jun 20]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/HEPA_AER_2022_Report.pdf"},{"key":"e_1_3_6_16_1","unstructured":"Press release: lowest number of recorded hepatitis a cases five other food and waterborne diseases rising towards pre-pandemic levels [internet]. ECDC; 2022 Dec 20. Available from: https:\/\/www.ecdc.europa.eu\/en\/news-events\/lowest-number-recorded-hepatitis-cases-five-other-food-and-waterborne-diseases-rising"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.19.2200575"},{"key":"e_1_3_6_18_1","unstructured":"European Center for Disease Prevention and Control. Hepatitis A. Annual epidemiological report for 2018. 2022 [cited 2024 Oct 3]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/HEPA_AER_2018_Report.pdf"},{"key":"e_1_3_6_19_1","unstructured":"European Center for Disease Prevention and Control. Hepatitis A. Annual epidemiological report for 2019. 2022 [cited 2024 Oct 3]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/HEPA_AER_2019_Report.pdf"},{"key":"e_1_3_6_20_1","unstructured":"World Health Organization. Action plan for the health sector response to viral hepatitis in the WHO European region 2016. [cited 2024 Jun 27]. Available from: https:\/\/www.globalhep.org\/sites\/default\/files\/content\/action_plan_article\/files\/2020-04\/EURO%20Action%20Plan%20for%20the%20health%20sector%20response%20to%20viral%20hepatitis%20in%20the%20WHO%20region.pdf"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.20.260919"},{"key":"e_1_3_6_22_1","unstructured":"European Center for Disease Prevention and Control. Epidemiological assessment of hepatitis B and C among migrants in the EU\/EEA Stockholm 2016. [cited 2024 Apr 19]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/epidemiological-assessment-hepatitis-B-and-C-among-migrants-EU-EEA.pdf"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2921-8"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13866"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.09.005"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044611"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00193-6"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2017.22.4.30448"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2017.11"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29185"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.07.006"},{"key":"#cr-split#-e_1_3_6_32_1.1","unstructured":"Coalition for Global Hepatitis Elimination. Action plan for the health sector response to viral hepatitis in the WHO European region 2016-2021. 2023 [updated 2024 Aug 20"},{"key":"#cr-split#-e_1_3_6_32_1.2","unstructured":"cited 2024 Apr 22]. Available from: https:\/\/www.globalhep.org\/tools-resources\/action-plans\/action-plan-health-sector-response-viral-hepatitis-who-european-region"},{"key":"e_1_3_6_33_1","unstructured":"World Health Organization. Viral hepatitis can be eliminated in the WHO European region by 2030 \u2013 here\u2019s how 2021. [cited 2024 Apr 22]. Available from: https:\/\/www.who.int\/europe\/news\/item\/27-07-2021-viral-hepatitis-can-be-eliminated-in-the-who-european-region-by-2030-here-s-how."},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa668"},{"key":"e_1_3_6_35_1","unstructured":"World Health Organization. Hepatitis B is preventable with safe and effective vaccines. [cited 2024 Jun 4]. Available from: https:\/\/www.who.int\/southeastasia\/activities\/hepatitis-b-is-preventable-with-safe-and-effective-vaccines"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32474"},{"key":"e_1_3_6_37_1","unstructured":"UK Health Security Agency. Hepatitis A: the green book chapter 17 2024. [cited 2024 May 2]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/65a1743269fbd3000d25c075\/Greenbook-chapter-17-hepatitis-A-12January24.pdf."},{"key":"e_1_3_6_38_1","unstructured":"UK Health Security Agency. Hepatitis B: the green book chapter 18 2024. [cited 2024 May 2]. Available from: https:\/\/assets.publishing.service.gov.uk\/media\/6628cbb0b0ace32985a7e535\/Hepatitis_B_Green_Book_chapter_18_20240423.pdf"},{"issue":"27","key":"e_1_3_6_39_1","first-page":"369","article-title":"Hepatitis B vaccines: WHO position paper \u2013 July 2017","volume":"92","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Hepatitis B vaccines: WHO position paper \u2013 July 2017. Wkly Epidemiol Rec. 2017;92(27):369\u2013392.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30204-3"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00850-X"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80044-8"},{"key":"e_1_3_6_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199607000-00006"},{"key":"e_1_3_6_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1338569"},{"key":"e_1_3_6_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv750"},{"key":"e_1_3_6_46_1","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20130022"},{"key":"e_1_3_6_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510410040030"},{"key":"e_1_3_6_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199208133270702"},{"key":"e_1_3_6_49_1","unstructured":"World Health Organization. The immunological basis for immunization series. Module 18: hepatitis a. Update. 2019 [cited 2024 Jun 4]. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/326501\/97892516327-eng.pdf?sequence=1"},{"key":"e_1_3_6_50_1","unstructured":"World Health Organization. Immunization coverage 2023. [cited 2024 Jun 5]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage"},{"key":"e_1_3_6_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac088"},{"key":"e_1_3_6_52_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7003a1"},{"key":"e_1_3_6_53_1","unstructured":"Centers for Disease Control and Prevention. Hepatitis B surveillance. 2020 [cited 2024 Oct 4]. Available from: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2020surveillance\/hepatitis-b.htm"},{"key":"e_1_3_6_54_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7113a1"},{"key":"e_1_3_6_55_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6905a1"},{"key":"e_1_3_6_56_1","unstructured":"Centers for Disease Control and Prevention. Vaccination coverage among adults in the United States. National health interview survey. 2021 [cited 2024 Jun 11]. Available from: https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/pubs-resources\/vaccination-coverage-adults-2021.html#:~:text=Hepatitis%20A%20vaccination%20(at%20least %25)%20than%20nontravelers%20(19.3%25)"},{"key":"e_1_3_6_57_1","unstructured":"Centers for Disease Control and Prevention. Hepatitis a surveillance 2022. [cited 2024 Jun 11]. Available from: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2022surveillance\/hepatitis-a.htm#anchor_03752"},{"key":"e_1_3_6_58_1","unstructured":"Centers for Disease Control and Prevention. Viral Hepatitis. National progress report 2025 goal: reduce estimated new hepatitis a virus infections by \u226540% 2021. [cited 2024 Sep 25]. Available from: https:\/\/www.cdc.gov\/hepatitis\/policy\/npr\/2021\/NationalProgressReport-HepA-ReduceInfections.htm#print"},{"key":"e_1_3_6_59_1","unstructured":"Centers for Disease Control and Prevention. Division of viral hepatitis: 2025 strategic plan. 2020 [cited 2024 Jun 11]. Available from: https:\/\/www.cdc.gov\/hepatitis\/pdfs\/DVH-StrategicPlan2020-2025.pdf"},{"key":"e_1_3_6_60_1","unstructured":"US Department of Health and Human Services. Viral hepatitis national strategic plan for the United States: a roadmap to elimination (2021\u20132025). 2020 [cited 2024 Jun 11]. Available from: https:\/\/www.hhs.gov\/sites\/default\/files\/Viral-Hepatitis-National-Strategic-Plan-2021-2025.pdf"},{"key":"e_1_3_6_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30392-4"},{"key":"e_1_3_6_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac492.1070"},{"key":"e_1_3_6_63_1","unstructured":"European Center for Disease Prevention and Control. Monitoring of the responses to the hepatitis B and C epidemics in EU\/EEA countries 2023. 2024 [cited 2024 Jun 18]. https:\/\/www.ecdc.europa.eu\/en\/publications-data\/monitoring-responses-hepatitis-b-and-c-epidemics-eueea-countries-2023"},{"key":"e_1_3_6_64_1","unstructured":"European Commission. Commission recommends new measures on vaccine-preventable cancers under Europe\u2019s beating cancer plan 2024. [cited 2024 Jun 13]. Available from: https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/IP_24_519."},{"key":"e_1_3_6_65_1","unstructured":"European Centre for Disease Prevention and Control. Prevention of hepatitis B and C in the EU\/EEA 2022 [updated 2022 Dec; Accessed on 2024]. Available from Mar 8. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/Evidence%20brief%20hepatitis%20B%20and%20C.pdf"},{"key":"e_1_3_6_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8010034"},{"key":"e_1_3_6_67_1","unstructured":"European Center for Disease Prevention and Control. Elimination targets progress. Prevention measures: progress towards the elimination targets. 2023 [cited 2024 Jun 12]. Available from: https:\/\/www.ecdc.europa.eu\/assets\/Prevention-Hepatitis-B-and-C\/elimination-targets-progress.html"},{"issue":"16","key":"e_1_3_6_68_1","first-page":"1\u201333; quiz CE1","article-title":"A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP) part II: immunization of adults","volume":"55","author":"Mast EE","year":"2006","unstructured":"Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices (ACIP) part II: immunization of adults. MMWR Recomm Rep. 2006;55(Rr\u201316):1\u201333; quiz CE1\u20134.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_6_69_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111645"},{"key":"e_1_3_6_70_1","unstructured":"National Foundation for Infectious Diseases. Call to action. Preventing hepatitis B in US adults through increased vaccination rates 2023. [cited 2024 Sep 29]. Available from: https:\/\/www.nfid.org\/wp-content\/uploads\/2023\/05\/Call-to-Action-Preventing-Hepatits-B-in-US-Adults-NFID.pdf"},{"key":"e_1_3_6_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000118"},{"key":"e_1_3_6_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.05.047"},{"key":"e_1_3_6_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.01.037"},{"key":"e_1_3_6_74_1","unstructured":"Hepatitis B Foundation. Call to action. Eliminating hepatitis B virus through universal screening and vaccination for adults ages 19\u201359 2023. [cited 2024 Mar 13]. Available from: https:\/\/www.hepb.org\/assets\/Uploads\/FINALv3-Call-to-Action-Universal-HBV-Screening-and-Vaccination-03.13.2023.pdf"},{"key":"e_1_3_6_75_1","unstructured":"British Medical Association. Hepatitis B vaccinations 2020. [cited 2024 Jun 12]. Available from: https:\/\/www.bma.org.uk\/advice-and-support\/gp-practices\/vaccinations\/hepatitis-b-vaccinations"},{"key":"e_1_3_6_76_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11101531"},{"key":"e_1_3_6_77_1","unstructured":"European Association for the Study of the Liver. The final push to eliminate viral hepatitis 2022. [cited 2024 Jun 27]. Available from: https:\/\/easl.eu\/wp-content\/uploads\/2022\/11\/221118-Final-Report_MEP-Friends-Liver-Group-event36.pdf"},{"key":"e_1_3_6_78_1","unstructured":"Service-Public.fr. Hepatitis vaccinations 2021. [cited 2024 Jun 12]. Available from: https:\/\/www.service-public.fr\/particuliers\/vosdroits\/F723?lang=en"},{"key":"e_1_3_6_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10903-022-01448-z"},{"key":"e_1_3_6_80_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i30.2955"},{"key":"e_1_3_6_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2021.101852"},{"key":"e_1_3_6_82_1","doi-asserted-by":"publisher","DOI":"10.3389\/ijph.2022.1604792"},{"key":"e_1_3_6_83_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-023-00420-8"},{"key":"e_1_3_6_84_1","doi-asserted-by":"publisher","DOI":"10.5334\/aogh.4388"},{"key":"e_1_3_6_85_1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taae094"},{"key":"e_1_3_6_86_1","unstructured":"World Health Organization. New report on tuberculosis HIV and viral hepatitis services for refugees and migrants across the WHO European region 2022. [cited 2024 Apr 19]. Available from: https:\/\/www.who.int\/europe\/news\/item\/22-02-2022-new-report-on-tuberculosis-hiv-and-viral-hepatitis-services-for-refugees-and-migrants-across-the-who-european-region"},{"key":"e_1_3_6_87_1","unstructured":"Press release: vaccines Europe statement on vaccine-preventable cancers. efpia; 2021. Available from: https:\/\/www.vaccineseurope.eu\/news\/press-releases\/vaccines-europe-statement-on-vaccine-preventable-cancers"},{"key":"e_1_3_6_88_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1118227"},{"key":"e_1_3_6_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08861-1"},{"key":"e_1_3_6_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac136"},{"key":"e_1_3_6_91_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.21.2400272"},{"key":"e_1_3_6_92_1","doi-asserted-by":"publisher","DOI":"10.3390\/v15010087"},{"key":"e_1_3_6_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2024.105622"},{"key":"#cr-split#-e_1_3_6_94_1.1","unstructured":"European Center for Disease Prevention and Control. Hepatitis a virus in the EU\/EEA 1975-2014 Stockholm 2016 [updated 2016 July"},{"key":"#cr-split#-e_1_3_6_94_1.2","unstructured":"cited 2024 Oct 6]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/hepatitis-a-virus-EU-EEA-1975-2014.pdf"},{"key":"e_1_3_6_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071271"},{"key":"e_1_3_6_96_1","doi-asserted-by":"publisher","DOI":"10.1057\/s41271-021-00293-y"},{"key":"e_1_3_6_97_1","unstructured":"Food Safety News. Publisher\u2019s platform: it is past time to vaccinate food service workers against hep a 2023. [cited 2024 Jun 20]. Available from: https:\/\/www.foodsafetynews.com\/2023\/11\/publishers-platform-it-is-past-time-to-vaccinate-food-service-workers-against-hep-a\/"},{"key":"e_1_3_6_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac185"},{"key":"e_1_3_6_99_1","volume-title":"Hepatitis a","author":"Centers for Disease Control and Prevention","year":"2021","unstructured":"Centers for Disease Control and Prevention. Hepatitis a. Washington (DC): Public Health Foundation. Available from 2021. Available from: https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/index.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/hepa.pdf"},{"key":"e_1_3_6_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2015.02.004"},{"key":"e_1_3_6_101_1","volume-title":"Brussels. Belgian health care knowledge","author":"Beutels P","year":"2008","unstructured":"Beutels P, Luyten J, Lejeune O, et al. Evaluation of universal and targeted hepatitis A vaccination programs in Belgium [Evaluatie van universele en doelgroep hepatitis A vaccinatie opties in Belgi\u00eb]. In: Brussels. Belgian health care knowledge. Centre (KCE): Health Technology Assessment (HTA); 2008. Available from: https:\/\/kce.fgov.be\/sites\/default\/files\/2021-11\/d20081027388.pdf"},{"key":"e_1_3_6_102_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826010-00003"},{"key":"e_1_3_6_103_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1242539"},{"key":"e_1_3_6_104_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031682"},{"key":"e_1_3_6_105_1","first-page":"77","article-title":"Hepatitis a vaccines - impact of universal childhood vaccination programmes","volume":"7","author":"Shouval D","year":"2011","unstructured":"Shouval D, Mikhaylov M, Van Herck K. Hepatitis a vaccines - impact of universal childhood vaccination programmes. Eur Gastroenterol Hepatol Rev. 2011;7:77\u201383.","journal-title":"Eur Gastroenterol Hepatol Rev"},{"key":"e_1_3_6_106_1","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s12160482"},{"key":"e_1_3_6_107_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2018.23.22.1700583"},{"key":"e_1_3_6_108_1","unstructured":"European Center for Disease Prevention and Control. Infectious diseases of specific relevance to newly-arrived migrants in the EU\/EEA 2015. [cited 2024 Jun 14]. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/Infectious-diseases-of-specific-relevance-to-newly-arrived-migrants-in-EU-EEA.pdf"},{"key":"e_1_3_6_109_1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/tax016"},{"key":"e_1_3_6_110_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031716"},{"issue":"5","key":"e_1_3_6_111_1","first-page":"549","article-title":"Infectious risk profile and strategies for prevention and control of outbreaks in refugee, asylum seekers and migrant populations in EU\/EEA countries: a systematic narrative review of evidence","volume":"36","author":"Bianchi FP","year":"2024","unstructured":"Bianchi FP, Fiacchini D, Frisicale EM, et al. Infectious risk profile and strategies for prevention and control of outbreaks in refugee, asylum seekers and migrant populations in EU\/EEA countries: a systematic narrative review of evidence. Ann Ig. 2024;36(5):549\u2013568.","journal-title":"Ann Ig"},{"key":"e_1_3_6_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00193-6"},{"key":"e_1_3_6_113_1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taac013"},{"key":"e_1_3_6_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102283"},{"key":"e_1_3_6_115_1","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taw069"},{"key":"#cr-split#-e_1_3_6_116_1.1","unstructured":"Okorite Ephraim & Boots Pharmacy Team. Travel vaccinations & health advice service. Avoiding hepatitis a 2024 [updated 2024 Mar 8"},{"key":"#cr-split#-e_1_3_6_116_1.2","unstructured":"Accessed on 2024]. Available from Jun 17. Available from: https:\/\/www.boots.com\/healthhub\/travel-health-advice\/hepatitis-a-vaccination"},{"key":"e_1_3_6_117_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riae024"},{"key":"e_1_3_6_118_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy6040125"},{"key":"e_1_3_6_119_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy8020102"},{"key":"e_1_3_6_120_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy7010005"},{"key":"e_1_3_6_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2022.102494"},{"key":"e_1_3_6_122_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17217945"},{"key":"e_1_3_6_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2024.100447"},{"key":"e_1_3_6_124_1","unstructured":"Vaccine Confidence Project. State of vaccine confidence in EU 2022. 2022 [cited 2024 Jun 20]. Available from: https:\/\/www.vaccineconfidence.org\/our-work\/reports\/state-of-vaccine-confidence-in-eu-2022\/"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2025.2502030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T06:44:48Z","timestamp":1765521888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2025.2502030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/14760584.2025.2502030"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2025.2502030","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-02-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}